| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer JS Miller, Y Soignier, A Panoskaltsis-Mortari, SA McNearney, GH Yun, ... Blood 105 (8), 3051-3057, 2005 | 2007 | 2005 |
| Sarcoma derived from cultured mesenchymal stem cells J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ... Stem cells 25 (2), 371-379, 2007 | 811 | 2007 |
| Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25+ regulatory T cells EA Moseman, X Liang, AJ Dawson, A Panoskaltsis-Mortari, AM Krieg, ... The Journal of Immunology 173 (7), 4433-4442, 2004 | 795 | 2004 |
| Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1–dependent mechanism that is up-regulated by interleukin-13 SL Highfill, PC Rodriguez, Q Zhou, CA Goetz, BH Koehn, R Veenstra, ... Blood, The Journal of the American Society of Hematology 116 (25), 5738-5747, 2010 | 507 | 2010 |
| A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer MA Geller, S Cooley, PL Judson, R Ghebre, LF Carson, PA Argenta, ... Cytotherapy 13 (1), 98-107, 2011 | 492 | 2011 |
| L-Selectinhi but not the L-selectinlo CD4+ 25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection PA Taylor, A Panoskaltsis-Mortari, JM Swedin, PJ Lucas, RE Gress, ... Blood 104 (12), 3804-3812, 2004 | 437 | 2004 |
| Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein V Bachanova, S Cooley, TE Defor, MR Verneris, B Zhang, DH McKenna, ... Blood, The Journal of the American Society of Hematology 123 (25), 3855-3863, 2014 | 435 | 2014 |
| Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded AP Price, KA England, AM Matson, BR Blazar, A Panoskaltsis-Mortari Tissue engineering Part A 16 (8), 2581-2591, 2010 | 432 | 2010 |
| Stem cells and cell therapies in lung biology and lung diseases DJ Weiss, I Bertoncello, Z Borok, C Kim, A Panoskaltsis-Mortari, ... Proceedings of the American thoracic society 8 (3), 223-272, 2011 | 431 | 2011 |
| Leukocyte migration and graft-versus-host disease CA Wysocki, A Panoskaltsis-Mortari, BR Blazar, JS Serody Blood 105 (11), 4191-4199, 2005 | 403 | 2005 |
| Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism BR Blazar, BM Carreno, A Panoskaltsis-Mortari, L Carter, Y Iwai, H Yagita, ... The Journal of Immunology 171 (3), 1272-1277, 2003 | 395 | 2003 |
| In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations MJ Carlson, ML West, JM Coghill, A Panoskaltsis-Mortari, BR Blazar, ... Blood, The Journal of the American Society of Hematology 113 (6), 1365-1374, 2009 | 381 | 2009 |
| Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 MK Gleason, TR Lenvik, V McCullar, M Felices, MS O'Brien, SA Cooley, ... Blood, the Journal of the American Society of Hematology 119 (13), 3064-3072, 2012 | 374 | 2012 |
| IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced … DA Vallera, M Felices, R McElmurry, V McCullar, X Zhou, JU Schmohl, ... Clinical Cancer Research 22 (14), 3440-3450, 2016 | 347 | 2016 |
| Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study JW Bauer, M Petri, FM Batliwalla, T Koeuth, J Wilson, C Slattery, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 337 | 2009 |
| An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome A Panoskaltsis-Mortari, M Griese, DK Madtes, JA Belperio, IY Haddad, ... American journal of respiratory and critical care medicine 183 (9), 1262-1279, 2011 | 322 | 2011 |
| Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation D Min, PA Taylor, A Panoskaltsis-Mortari, B Chung, DM Danilenko, ... Blood, The Journal of the American Society of Hematology 99 (12), 4592-4600, 2002 | 320 | 2002 |
| Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease CA Wysocki, QI Jiang, A Panoskaltsis-Mortari, PA Taylor, KP McKinnon, ... Blood 106 (9), 3300-3307, 2005 | 317 | 2005 |
| Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib K Sun, LA Welniak, A Panoskaltsis-Mortari, MJ O'Shaughnessy, H Liu, ... Proceedings of the National Academy of Sciences 101 (21), 8120-8125, 2004 | 315 | 2004 |
| IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial LJ Burns, DJ Weisdorf, TE DeFor, DH Vesole, TL Repka, BR Blazar, ... Bone marrow transplantation 32 (2), 177-186, 2003 | 311 | 2003 |
